Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 30;25(1):803.
doi: 10.1186/s12885-025-14034-x.

Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features

Affiliations
Free article

Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features

Xia Zhang et al. BMC Cancer. .
Free article

Abstract

Objectives: The epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is overexpressed in various epithelial tumors and has been associated with tumor aggressiveness and unfavorable prognosis. This study aimed to explore the association between ultrasonic characteristics and EpCAM expression in papillary thyroid carcinoma (PTC), as well as the value in predicting the risk of cervical lymph node metastasis (CLNM).

Methods: Participants with suspected thyroid cancer underwent conventional and contrast-enhanced ultrasonography (CEUS) before surgery. Age, sex, and nodule features in ultrasound were recorded. Participants were classified based on the presence of CLNM. EpCAM expression was detected using immunohistochemistry. The risk predictors of CLNM were evaluated by using univariate and multivariate Cox model.

Results: The final dataset included 53 participants, of whom 27(50.94%) had CLNM, while 26(49.06%) did not. The EpCAM-positive area (p < 0.001), score (p < 0.001), and nuclear expression (p = 0.027) were significantly different between the CLNM and non-CLNM groups. Receiver operating characteristic curve analysis showed that EpCAM score with 4.5 had sensitivity and specificity of 85.2% and 76.9%, respectively, for diagnosing CLNM. Multivariate logistic regression results showed that overexpression EpCAM (score ≧ 4.5) [OR:46.54, p = 0.007], tumor size ≧ 1.05 cm [OR:14.21,p = 0.01] and extrathyroidal extension (ETE) on CEUS [OR:113.33, p = 0.01] were independent risk factors of CLNM. Overexpression of EpCAM (62.07%, 18/29) correlated with ETE of PTC confirmed by postoperative pathology (p = 0.01, 0.027). No significant difference in PTC histological variants was detected based on EpCAM expression (p = 0.05).

Conclusions: EpCAM overexpression demonstrated a significant association with ETE and CLNM in PTC. The integration of ultrasonography with EpCAM expression profiling offers A promising multiparameter diagnostic model to enhance predictive accuracy. Further studies evaluating EpCAM expression in fine-needle aspiration biopsy (FNAB) samples are required to determine its possible preoperative predictive value.

Keywords: Cervical lymph node metastasis; Extrathyroidal extension; Papillary thyroid carcinoma; Ultrasonography.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: The studies involving human participants were reviewed and approved by Medical Ethics Committee of Chinese PLA General Hospital. Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Sun Y, Dai W, Liang Y, Xia N. Impact of age on the prognosis of papillary thyroid carcinoma. Arch Iran Med. 2020;23(3):169–74.
    1. Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall survival of papillary thyroid carcinoma participants: A Single-Institution Long-Term Follow-up of 5897 participants. Word J Surg. 2018;42(3):615–22. https://doi.org/10.1007/s00268-018-4479-z . - DOI
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551 . - DOI
    1. Hay ID, McConahey WM, Goellner JR. Managing participants with papillary thyroid carcinoma: insights gained from Mayo clinic’s experience of treating 2,512 consecutive participants during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002;113:241–60.
    1. Tuttle RM, Leboeuf R, Martorella AJ. Papillary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am (2007) 36 (3): 753– 78. doi: org/ https://doi.org/10.1016/j.ecl.2007.04.004

MeSH terms

Substances

LinkOut - more resources